Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. Big Data claims to be full of insights that Big Pharma need to find a way of harvesting, which could lead to new compounds. Academics, Big Data start-ups, and pharmaceutical companies have focused their research efforts on analytic tools and data technologies to store, collect, analyse, and extract these insights from massive data sets. However, the key question is whether the Big Data hype really does have the claimed accelerating effect on the complex research and development process or if it actually creates another hurdle for Big Pharma innovation. Malena Johannes' timely book sheds light on this question by examining the top 5 pharmaceutical companies and provides an overview on the status quo of Big Data applications within the pharmaceutical industry.
Le informazioni nella sezione "Riassunto" possono far riferimento a edizioni diverse di questo titolo.
EUR 4,50 per la spedizione da Germania a Italia
Destinazione, tempi e costiEUR 2,00 per la spedizione da Irlanda a Italia
Destinazione, tempi e costiDa: medimops, Berlin, Germania
Condizione: very good. Gut/Very good: Buch bzw. Schutzumschlag mit wenigen Gebrauchsspuren an Einband, Schutzumschlag oder Seiten. / Describes a book or dust jacket that does show some signs of wear on either the binding, dust jacket or pages. Codice articolo M03838209427-V
Quantità: 1 disponibili
Da: Buchpark, Trebbin, Germania
Condizione: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher. Codice articolo 26668172/2
Quantità: 1 disponibili
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Irlanda
Condizione: New. 2016. New. paperback. . . . . . Codice articolo V9783838209425
Quantità: 2 disponibili
Da: Revaluation Books, Exeter, Regno Unito
Paperback. Condizione: Brand New. 132 pages. 8.27x5.83x0.03 inches. In Stock. Codice articolo 3838209427
Quantità: 1 disponibili
Da: PBShop.store US, Wood Dale, IL, U.S.A.
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo GZ-9783838209425
Quantità: 7 disponibili
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000. Codice articolo GZ-9783838209425
Quantità: 7 disponibili
Da: Kennys Bookstore, Olney, MD, U.S.A.
Condizione: New. 2016. New. paperback. . . . . . Books ship from the US and Ireland. Codice articolo V9783838209425
Quantità: 2 disponibili
Da: Majestic Books, Hounslow, Regno Unito
Condizione: New. pp. 132. Codice articolo 393717347
Quantità: 3 disponibili
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 132. Codice articolo 26385882556
Quantità: 3 disponibili
Da: moluna, Greven, Germania
Condizione: New. Raising costs, ever-increasing regulatory hurdles, and mounting difficulties in finding the next blockbuster drug are just a few of the challenges Big Pharma currently has to face for its research and development process, the heart of its risky business. . Codice articolo 118772909
Quantità: 5 disponibili